Vistagen TherapeuticsVTGN
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 42 institutions reported holding Vistagen Therapeutics Inc. (VTGN) in their 13F filings, up 1 from Q1 2024. 7 opened new positions and 6 sold out. The largest holders were BVF Inc. ($7.0M), Vanguard Group Inc. ($6.2M) and Stempoint Capital LP ($5.8M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Vistagen Therapeutics Inc.
- CUSIP
- 92840H400
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $173K |
| Exits | 6 | $979K |
All 13F filers, Q1 2024 → Q2 2024: 173,062 shares bought and 1,125,191 shares sold, net −952,129 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 42 holders
| BVF Inc. | 0.20% | No change | 2,000,000 | $7.0M |
| Vanguard Group Inc. | 0.00% | No change | 1,793,166 | $6.2M |
| Stempoint Capital LP | 1.72% | No change | 1,848,582 | $5.8M |
| Commodore Capital LP | 0.37% | No change | 1,575,000 | $5.5M |
| Great Point Partners LLC | 1.02% | Reduce -17.7% | 1,529,338 | $5.3M |
| Nantahala Capital Management, LLC | 0.53% | No change | 1,517,696 | $5.3M |
| Sphera Funds Management LTD. | 0.46% | No change | 808,550 | $2.8M |
| Citadel Advisors | 0.00% | Reduce -15.4% | 629,645 | $2.2M |
| BlackRock Inc. | 0.00% | Add +15.6% | 402,747 | $1.4M |
| Armistice Capital, LLC | 0.03% | Reduce -17.6% | 300,000 | $1.0M |
| Geode Capital Management, LLC | 0.00% | Add +3.8% | 290,094 | $1.0M |
| Goldman Sachs Group Inc. | 0.00% | Add +5.3% | 174,982 | $609K |
| BML Capital Management, LLC | 0.38% | No change | 150,000 | $522K |
| State Street Corp. | 0.00% | Add +6.0% | 88,708 | $309K |
| Blair William & Co. | 0.00% | Add +29.2% | 88,466 | $308K |
| Two Sigma Investments, LP | 0.00% | Reduce -53.2% | 67,511 | $235K |
| Susquehanna International Group, LLP | 0.00% | Reduce -77.5% | 65,107 | $227K |
| Renaissance Technologies | 0.00% | Reduce -40.9% | 64,900 | $226K |
| AdvisorShares Investments LLC | 0.03% | Reduce -28.1% | 51,780 | $185K |
| Northern Trust Corp. | 0.00% | Reduce -0.1% | 49,962 | $174K |
| American Century Companies Inc. | 0.00% | Add +49.1% | 30,315 | $105K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 23,302 | $81K |
| UBS Group AG | 0.00% | Add +306.8% | 19,266 | $67K |
| Barclays PLC | 0.00% | Reduce -16.5% | 19,261 | $67K |
| Simplex Trading, LLC | 0.00% | New | 17,107 | $59K |
| Virtu Financial LLC | 0.00% | New | 15,488 | $54K |
| Squarepoint Ops LLC | 0.00% | New | 11,395 | $40K |
| Osaic Holdings, Inc. | 0.00% | Reduce -5.4% | 11,026 | $38K |
| Morgan Stanley | 0.00% | Reduce -72.7% | 5,866 | $20K |
| FMR LLC | 0.00% | New | 4,146 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -27.9% | 2,484 | $9K |
| Cwm, LLC | 0.00% | No change | 2,416 | $8K |
| Royal Bank of Canada | 0.00% | New | 1,081 | $4K |
| Bfsg, LLC | 0.00% | No change | 1,000 | $3K |
| Qube Research & Technologies Ltd | 0.00% | New | 492 | $2K |
| Bank of America Corp. | 0.00% | Reduce -97.7% | 238 | $829 |
| SJS Investment Consulting Inc. | 0.00% | New | 100 | $348 |
| Farther Finance Advisors, LLC | 0.00% | No change | 81 | $289 |
| Jones Financial Companies LLLP | 0.00% | No change | 80 | $278 |
| Fairman Group, LLC | 0.00% | No change | 29 | $101 |
| JPMorgan Chase & Co. | 0.00% | No change | 16 | $56 |
| Citigroup Inc. | 0.00% | Reduce -100.0% | 3 | $10 |
"% of holder's portfolio" is VTGN's weight in each manager's 13F, not the share of Vistagen Therapeutics Inc. the manager owns.